Andreas Schwiertz

Prof. Andreas Schwiertz

Institute of Microecology
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Obesity
Verified
Journal Article
Closed access
PDF file
Andreas SchwiertzAndreas Schwiertz
Andreas Schwiertz
DTDavid Taras
David Taras
KSKlaus Schäfer
Klaus Schäfer
SBSilvia Beijer
Silvia Beijer
NBNicolaas A. Bos
Nicolaas A. Bos
PHPhilip D. Hardt
Philip D. Hardt

1 November 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
MUMarcus M. Unger
Marcus M. Unger
JSJörg Spiegel
Jörg Spiegel
KDKlaus-Ulrich Dillmann
Klaus-Ulrich Dillmann
DGDavid Grundmann
David Grundmann
HPHannah Philippeit
Hannah Philippeit
KSKarl-Herbert Schäfer
Karl-Herbert Schäfer

1 July 2003 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
GHGeorgina Louise Hold
Georgina Louise Hold
Andreas SchwiertzAndreas Schwiertz
Andreas Schwiertz
Rustam AminovRustam Aminov
Rustam Aminov
MBMichael Blaut
Michael Blaut
HFHarry J. Flint
Harry J. Flint
16S rRNA-targeted oligonucleotide probes were designed for butyrate-producing bacteria from human feces. Three new cluster-specific probes detected bacteria related toRoseburia intestinalis,Faecalibacterium prausnitzii, andEubacterium halliiat mean populations of 2.3, 3.8, and 0.6%, respectively, in samples from 10 individuals. Additional species-level probes accounted for no more than 1%, with a mean of 7.7%, of the total human fecal microbiota identified as butyrate producers in this study. Bacteria related toE. halliiand the generaRoseburiaandFaecalibacteriumare therefore among the most abundant known butyrate-producing bacteria in human feces.

30 December 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
CBCarolin Brandscheid
Carolin Brandscheid
FSFlorian Schuck
Florian Schuck
SRSven Reinhardt
Sven Reinhardt
KSKarl-Herbert Schäfer
Karl-Herbert Schäfer
CPClaus U. Pietrzik
Claus U. Pietrzik
Kristina EndresKristina Endres
Kristina Endres
The regulation of physiological gut functions such as peristalsis or secretion of digestive enzymes by the central nervous system via the Nervus vagus is well known. Recent investigations highlight that pathological conditions of neurological or psychiatric disorders might directly interfere with the autonomous neuronal network of the gut – the enteric nervous system, or even derive from there. By using a murine Alzheimer’s disease model, we investigated a potential influence of disease-associated changes on gastrointestinal properties. 5xFAD mice at three different ages were compared to wild type littermates in regard to metabolic parameters and enzymes of the gut by fluorimetric enzyme assay and western blotting. Overexpression of human amyloid-β protein precursor (AβPP) within the gut was assessed by qPCR and IHC; fecal microbiome analysis was conducted by 16SrRNA quantitation of selected phyla and species. While general composition of fecal samples, locomotion, and food consumption of male 5xFAD animals were not changed, we observed a reduced body weight occurring at early pathological stages. Human AβPP was not only expressed within the brain of these mice but also in gut tissue. Analysis of fecal proteins revealed a reduced trypsin amount in the 5xFAD model mice as compared to the wild type. In addition, we observed changes in fecal microbiota composition along with age. We therefore suggest that the presence of the mutated transgenes (AβPP and PS1), which are per se the basis for the genetic form of Alzheimer’s disease in humans, directly interferes with gut function as shown here for the disease model mice.

27 May 2016 in Scientific Reports
Verified
Journal Article
Open access
Isabelle MackIsabelle Mack
Isabelle Mack
UCUlrich Cuntz
Ulrich Cuntz
CGClaudia Grämer
Claudia Grämer
SNSabrina Niedermaier
Sabrina Niedermaier
CPCharlotte Pohl
Charlotte Pohl
JPJohn Penders
John Penders
The gut microbiota not only influences host metabolism but can also affect brain function and behaviour through the microbiota-gut-brain axis. To explore the potential role of the intestinal microbiota in anorexia nervosa (AN), we comprehensively investigated the faecal microbiota and short-chain fatty acids in these patients before (n = 55) and after weight gain (n = 44) in comparison to normal-weight participants (NW, n = 55) along with dietary intake and gastrointestinal complaints. We show profound microbial perturbations in AN patients as compared to NW participants, with higher levels of mucin-degraders and members of Clostridium clusters I, XI and XVIII and reduced levels of the butyrate-producing Roseburia spp. Branched-chain fatty acid concentrations, being markers for protein fermentation, were elevated. Distinct perturbations in microbial community compositions were observed for individual restrictive and binge/purging AN-subtypes. Upon weight gain, microbial richness increased, however perturbations in intestinal microbiota and short chain fatty acid profiles in addition to several gastrointestinal symptoms did not recover. These insights provide new leads to modulate the intestinal microbiota in order to improve the outcomes of the standard therapy.

1 May 2018 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
Andreas SchwiertzAndreas Schwiertz
Andreas Schwiertz
JSJörg Spiegel
Jörg Spiegel
UDUlrich Dillmann
Ulrich Dillmann
DGDavid Grundmann
David Grundmann
JBJan Bürmann
Jan Bürmann
MUMarcus M. Unger
Marcus M. Unger